Clinical Trial Update: The Boceprevir and Sildenafil Pharmacokinetics Study [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study evaluating the interaction between boceprevir and sildenafil in Hepatitis C patients has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Imperial College London | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2014-11-07